reddy’s

Latest stories

  • in Health care

    Dr Reddys Labs unveils Treprostinil Injection in US

    by

    Hyderabad: Dr. Reddy’s Laboratories Ltd. has announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic version of Remodulin (treprostinil) Injection, approved by U. S. Food and Drug Administration (USFDA).  Treprostinil injection is a prostacyclin mimetic indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated […] More

  • 12 Views

    in Health care

    Dr Reddy’s Labs names Sonu Sood as brand ambassador for Rebalanz Vitors

    by

    Hyderabad: Dr. Reddy’s Laboratories Limited on Tuesday announced that it has roped in fitness enthusiast, actor and philanthropist, Sonu Sood as its brand ambassador for Rebalanz Vitors. Launched in 2018, Rebalanz Vitors has grown rapidly to occupy a significant market position in the Ready-to- Serve fruit beverage segment, amongst existing and new players, Hyderabad-based Pharmaceutical […] More

  • in Health care

    Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy’s over Tegoprazan

    Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy's over Tegoprazan

    by

    New Delhi: In response to the proposal to conduct a Phase III clinical trial presented by the drug major Reddy’s Laboratories, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the firm to revise the protocol of Phase III clinical trial of the drug Tegoprazan with respect to the […] More

  • in Health care

    Dr Reddys Labs concludes acquisition of Mayne Pharma’s US generic prescription product portfolio

    Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio

    by

    Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma’s U.S. generic prescription product portfolio. The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health. For the financial period ended June […] More